3rd Quarter - Report
TIBER CREEK GROUP for JAZZ PHARMACEUTICALS
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Issues related to the FDA and the STATES Act (S. 3032), HHS pertaining to CBD policy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| EMILY KIRLIN | — |
| MATTHEW LEFFINGWELL | — |
| TIMOTHY A MOLINO | — |
Budget/Appropriations BUD
Appropriations issues related to the FDA CBD products, HHS pertaining to CBD policy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| EMILY KIRLIN | — |
| MATTHEW LEFFINGWELL | — |
| TIMOTHY A MOLINO | — |
Health Issues HCR
Issues related to the FDA STATES Act (S. 3032), and Health and Human Services pertaining to CBD policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| EMILY KIRLIN | — |
| MATTHEW LEFFINGWELL | — |
| TIMOTHY A MOLINO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.